|
0
|
|
In Critical Condition: The Urgent Need to Support Mpox Therapeutic and Diagnostic Pipelines.
(academic.oup.com)
|
Perez Casas C
…
Fallah MP
Clinical Infectious Diseases
2026-02-25
|
#amr
#clinical trial
#therapeutics
#antiviral
#diagnostics
|
|
0
|
|
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naive Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8.
(academic.oup.com)
|
Scott PT
…
Platt HL
Clinical Infectious Diseases
2026-02-25
|
#vaccination
#clinical trial
#immunogenicity
#safety
#pneumococcal
|
|
0
|
|
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083.
(academic.oup.com)
|
Clement ME
…
Landovitz RJ
Clinical Infectious Diseases
2026-02-25
|
#infection
#amr
#clinical trial
#prevention
#hiv
|
|
0
|
|
Risk Assessment in a Global CVD Prevention Cohort of People With HIV by PCE, PREVENT, and SCORE2.
(academic.oup.com)
|
Grinspoon SK
…
Zanni MV
Clinical Infectious Diseases
2026-02-25
|
#clinical trial
#prevention
#hiv
#cardiovascular
#risk stratification
|
|
0
|
|
Adherence to legislation and recommendations to publicly post protocols and results of post-authorisation studies registered with European Medicines Agency: cross sectional study.
(bmj.com)
|
Ramezani P
…
Prugger C
BMJ
2026-02-25
|
#clinical trial
#regulation
#pharmacovigilance
#transparency
|